Retatrutide Lyophilized Vial: Manufacturing & OEM
ShiLai™ Healthcare manufactures Retatrutide lyophilized vials for research and OEM programs. Lyophilization (freeze-drying) provides enhanced stability for peptide formulations, extending shelf life and simplifying storage and shipping.
Why Lyophilized Retatrutide?
Lyophilized (freeze-dried) Retatrutide offers superior stability compared to liquid formulations. The lyophilization process removes water under vacuum, producing a dry powder that is reconstituted before use. This format is well-suited for long-distance shipping and extended storage.
Retatrutide Vial Specifications
We offer Retatrutide lyophilized vials in various concentrations and fill configurations. Standard and custom vial sizes are available for OEM programs. Each vial is sealed under inert atmosphere and labeled with batch information.
Analytical Documentation
Each batch of Retatrutide lyophilized vials is tested by RP-HPLC for purity and LC-MS for identity. A Certificate of Analysis (COA) is provided. Water content testing is available on request.
Frequently Asked Questions
What is a lyophilized Retatrutide vial?
A lyophilized Retatrutide vial contains freeze-dried Retatrutide peptide. The lyophilization process removes water to produce a stable dry powder that is reconstituted with sterile water or bacteriostatic water before use.
How is Retatrutide lyophilized vial purity verified?
ShiLai™ Healthcare verifies Retatrutide purity by RP-HPLC and confirms identity by LC-MS. A Certificate of Analysis (COA) is provided with each batch.